Pharmaceutics

CMA warns drug companies against using discount schemes to maintain market dominance

The Competition and Markets Authority has warned drug companies against using anti-competitive discount schemes to protect dominant market position, after investigating discounts offered by the company that manufactures Remicade.…

FDA approves new generic valsartan to address shortages

The US Food and Drug Administration has approved a new generic valsartan to help relieve recent shortages of the medicine.…

Bulk shipment of medical cannabis delivered to UK

What is thought to be the first bulk shipment of medical cannabis brought into the UK was delivered on 14 February 2019.…

Government drugs advisory body to review impact of medical cannabis reschedule

The Advisory Council for the Misuse of Drugs has been asked by the Home Office to begin a long-term review into cannabis-based products for medical use.…

NHS review finds ‘majority’ of pharmacy aseptic services cannot fund maintenance

Most aseptic pharmacy services in England are unable pay for maintenance and servicing due to a poor understanding of the costs involved, an NHS report has said.…

Qualified Persons: seven things pharmacists need to know

Carol Candlish and Kina Vyas explain the role of a Qualified Person and how pharmacists in the UK can become one.…

EMA recommends sartan manufacturers review processes to avoid contamination

The European Medicines Agency has recommended that manufacturers making sartan blood pressure medicines review their processes after impurities were found in a small number of products.…

Davos report highlights UK doctors’ fears around medical cannabis prescribing

UK-based specialist doctors may be reluctant to prescribe medical cannabis because there is a lack of “infrastructure to support them should something go wrong”, the World Economic Forum’s annual meeting has heard.…

Brexit could have ‘moderately positive impact’ on medicine manufacturing in the UK, says Welsh report

Brexit could have a “moderately positive impact” on the development of the UK pharmaceutical sector in the long term, according to a Health Impact Assessment report published by Public Health Wales.…

Refrigeration storage for no-deal Brexit medicines stockpiles to cost £1m

The government is expecting to spend around £1m on refrigerated storage for medicine stockpiles in the event of a no-deal Brexit.…